As BRCA1, BRCA2, and ATM proteins interact in the HR pathway, an additive effect on HR deficiency could be expected, giving a further increased risk of pancreatic cancer, as observed in patients 1, 4, and 5. The gene discussed is BRCA2; the disease is familial pancreatic carcinoma.